Retraction: Circulating MicroRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: A meta-analysis based on 42 articles (PLoS ONE (2014) 9:11 (e113401) DOI: 10.1371/journal.pone.0113401);Circulating MicroRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: A meta-analysis based on 42 articles

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Wang, Ran ^a,b   Wen, Hong ^b   Xu, Yongcheng ^b   Chen, Qiulan ^b   Luo, Yi ^b   Lin, Yiqin ^b   Luo, Yu ^b   Xu, Angao ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; SMALL UNTRANSLATED RNA; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; HUMAN; META ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SYSTEMATIC REVIEW; BLOOD; GASTROINTESTINAL NEOPLASMS; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOMARKERS, TUMOR; GASTROINTESTINAL NEOPLASMS; HUMANS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84914673294     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0251146     Document Type: Erratum

References (77)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
3. Suzuki H, Gotoda T, Sasako M, Saito D (2006) Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer 9: 315-319.
4. McFarland EG, Levin B, Lieberman DA, Pickhardt PJ, Johnson CD, et al. (2008) Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology 248: 717-720.
5. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374: 477-490.
6. Takahashi S, Hirayama M, Kuroiwa G, Kawano Y, Takada K, et al. (2013) Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis. Gastric Cancer 16: 543-548.
7. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, et al. (2014) Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 146: 709-717.
8. Neri E, Faggioni L, Cerri F, Turini F, Angeli S, et al. (2010) CT colonography versus double-contrast barium enema for screening of colorectal cancer: comparison of radiation burden. Abdom Imaging 35: 596-601.
9. Duffy MJ (2007) Role of tumor markers in patients with solid cancers: A critical review. Eur J Intern Med 18: 175-184.
10. Choong MK, Tsafnat G (2012) Genetic and epigenetic biomarkers of colorectal cancer. Clin Gastroenterol Hepatol 10: 9-15.
11. Tarro G, Perna A, Esposito C (2005) Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol 203: 1-5.
12. Sorio C, Mauri P, Pederzoli P, Scarpa A (2006) Non-invasive cancer detection: strategies for the identification of novel cancer markers. IUBMB Life 58: 193-198.
13. Dbouk HA, Tawil A, Nasr F, Kandakarjian L, Abou-Merhi R (2007) Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients. Open Clin Cancer J 1: 1-5.
14. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
15. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
16. Davis BN, Hata A (2009) Regulation of MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal 7: 18.
17. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741.
18. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
19. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
20. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
21. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179.
22. Zhang C, Wang C, Chen X, Yang C, Li K, et al. (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 56: 1871-1879.
23. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682.
24. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, et al. (2009) miRNAs in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
25. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBVpositive hepatocarcinoma. Cancer Res 70: 9798-9807.
26. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
27. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 12: 2171-2176.
28. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149: 889-897.
29. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536.
30. Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323: 157-162.
31. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
33. Jackson D, White IR, Thompson SG (2010) Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 29: 1282-1297.
34. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58: 882-893.
35. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, et al. (2010) Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 88: 709-717.
36. Liu R, Zhang C, Hu Z, Li G, Wang C, et al. (2011) A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 47: 784-791.
37. Zheng Y, Cui L, Sun W, Zhou H, Yuan X, et al. (2011) MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark 10: 71-77.
38. Zhu CJ, Zhang JY, Wei J, Liu YQ, Shu YQ (2011) [MiR-191 and miR-29a in plasma are promising novel biomakers for detection of gastric cancer]. Acta Universitatis Medicinalis Nanjing(Natural Science) 31: 1173-1178.
39. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, et al. (2012) Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre-and post-operative plasma. Br J Cancer 106: 740-747.
40. Li BS, Zhao YL, Guo G, Li W, Zhu ED, et al. (2012) Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 7: e41629.
41. Li ZQ, Huang PW, Zhu CJ, Chen CP, Cheng T, et al. (2012) [Diagnostic value of expressions of miR-27a and miR-181b for early detection of gastric cancer]. Jiangsu Med J 38: 1665-1667.
42. Liu H, Zhu L, Liu B, Yang L, Meng X, et al. (2012) Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316: 196-203.
43. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, et al. (2012) Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 7: e33608.
44. Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Diaz P, Lorenzo-Patino MJ, et al. (2012) Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 10: 186.
45. Wang B, Zhang Q (2012) The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 138: 1659-1666.
46. Zhou H, Xiao B, Zhou F, Deng H, Zhang X, et al. (2012) MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers 17: 104-110.
47. Cai H, Yuan Y, Hao YF, Guo TK, Wei X, et al. (2013) Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol 30: 452.
48. Li C, Li JF, Cai Q, Qiu QQ, Yan M, et al. (2013) miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol 20 Suppl 3: S397-405.
49. Sheinerman KS, Tsivinsky VG, Umansky SR (2013) Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study. J Transl Med 11: 304.
50. Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, et al. (2013) Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer 109: 2323-2330.
51. Xu Q, Dong QG, Sun LP, He CY, Yuan Y (2013) Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study. BMC Clin Pathol 13: 11.
52. Chen Q, Ge X, Zhang Y, Xia H, Yuan D, et al. (2014) Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol Rep 31: 1863-1870.
53. Peng WZ, Ma R, Wang F, Yu J, Liu ZB (2014) Role of miR-191/425 Cluster in Tumorigenesis and Diagnosis of Gastric Cancer. Int J Mol Sci 15: 4031-4048.
54. Zhu C, Ren C, Han J, Ding Y, Du J, et al. (2014) A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer.
55. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. International Journal of Cancer 127: 118-126.
56. Pu XX, Huang GL, Guo HQ, Guo CC, Li H, et al. (2010) Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol 25: 1674-1680.
57. Liu HS, Ma YY, Xiao HS (2012) [The diagnostic value of serum microRNAs including miR-129-3p, miR-767-3p and miR-877∗ for colorectal cancer]. Tumor 32: 42-48.
58. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, et al. (2012) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS ONE 7: e44398.
59. Feng L, Pang Z, Sha S, Wu B, Xu F, et al. (2013) [The value of diagnosis and prognosis prediction of serum miR-29a and miR-92a for colorectal cancer]. Chin J Clin Oncol Rehabil: 1313-1315.
60. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, et al. (2013) Circulating MicroRNAs as biomarkers of colorectal cancer: Results from a genome-wide profiling and validation study. Clinical Gastroenterology and Hepatology 11: 681-688.e683.
61. Liu GH, Zhou ZG, Chen R, Wang MJ, Zhou B, et al. (2013) Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer. Tumour Biol 34: 2175-2181.
62. Luo X, Stock C, Burwinkel B, Brenner H (2013) Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS ONE 8: e62880.
63. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, et al. (2013) Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. Journal of the National Cancer Institute 105: 849-859.
64. Wang S, Xiang J, Li Z, Lu S, Hu J, et al. (2013) A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer.
65. Yong FL, Law CW, Wang CW (2013) Potentiality of a triple microRNA classifier: MiR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer 13.
66. Zhang GJ, Zhou T, Liu ZL, Tian HP, Xia SS (2013) Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma. Molecular and Clinical Oncology 1: 379-384.
67. Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, et al. (2014) Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer 110: 1001-1007.
68. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 105: 104-111.
69. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, et al. (2011) The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) 121: 437-447.
70. Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, et al. (2013) Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 108: 1822-1829.
71. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, et al. (2013) Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer 108: 644-652.
72. Zhang T, Zhao D, Wang Q, Yu X, Cui Y, et al. (2013) MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol Carcinog 52: 581-590.
73. Redova M, Sana J, Slaby O (2013) Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol 9: 387-402.
74. Shen J, Stass SA, Jiang F (2013) MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 329: 125-136.
75. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
76. Sita-Lumsden A, Dart DA, Waxman J, Bevan CL (2013) Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer 108: 1925-1930.
77. Zen K, Zhang CY (2012) Circulating MicroRNAs: A novel class of biomarkers to diagnose and monitor human cancers. Medicinal Research Reviews 32: 326-348.